Codexis Announces New Employment Inducement Grants
May 08, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to five new employees as...
Codexis Reports First Quarter 2023 Financial Results
May 04, 2023 16:05 ET
|
Codexis, Inc.
CDX-7108 Clinical Development Program Remains on Track Estimated Cash Runway Through End of 2024 Funds Important Upcoming Milestones Company Reiterates 2023 Total Revenue Guidance with...
Codexis to Report First Quarter 2023 Financial Results on May 4
April 20, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first...
Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA
April 19, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a pre-conference workshop highlighting the...
Codexis Announces New Employment Inducement Grants
April 06, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as...
Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors
April 04, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that Patrick Yang, PhD, will not seek re-election to the...
Codexis Announces New Employment Inducement Grants
March 09, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as...
Codexis to Participate in Cowen 43rd Annual Health Care Conference
February 27, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that management will participate in both a panel discussion...
Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 23, 2023 16:06 ET
|
Codexis, Inc.
Biotherapeutics Application of CodeEvolver® Validated by Recent Data Supporting the Potential for Three Upcoming Investigational New Drug Applications Cash Runway Through End of 2024 Funds Important...
Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency
February 23, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, and Nestlé Health Science, a leader in the science of nutrition, today...